AQST vs OGN · rev $28.3M vs P/E 3.4, rev $3.02B
Aquestive Therapeutics Inc (AQST) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
AQST currently screens at market cap $493.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the AQST and OGN stock pages for the full models.
Not investment advice.